Benzodiazepine, psychotropic medication, and dementia: A population-based cohort study

Alzheimer's and Dementia

Volumn 12, Issue 5, 2016, Pages 604-613

  Shash, Dalia ^a,b   Kurth, Tobias ^a,b   Bertrand, Marion ^a   Dufouil, Carole ^a,b   Barberger Gateau, Pascale ^a,b   Berr, Claudine ^c   Ritchie, Karen ^c   Dartigues, Jean Francois ^a,b   Bégaud, Bernard ^b,d   Alpérovitch, Annick ^a,b   Tzourio, Christophe ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c INSERM U1061   (France)

^d INSERM U657   (France)

Author keywords

Alzheimer's disease; Benzodiazepine; Cohort studies; Dementia; Psychotropic medication

Indexed keywords

ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; HYPNOTIC SEDATIVE AGENT; PSYCHOTROPIC AGENT; BENZODIAZEPINE DERIVATIVE;

ALCOHOL CONSUMPTION; ANXIETY; ARTICLE; CLINICAL EXAMINATION; COHORT ANALYSIS; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DRUG HALF LIFE; DRUG USE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; AGED; CHEMICALLY INDUCED; RISK;

AGED; BENZODIAZEPINES; DEMENTIA; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; PSYCHOTROPIC DRUGS; RISK;

EID: 84953438816     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2015.10.006     Document Type: Article

References (29)

1. R. Lagnaoui, F. Depont, A. Fourrier, A. Abouelfath, B. Begaud, H. Verdoux, and et al. Patterns and correlates of benzodiazepine use in the French general population Eur J Clin Pharmacol 60 2004 523 529
2. A. Fourrier, L. Letenneur, J.F. Dartigues, N. Moore, and B. Begaud Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use Eur J Clin Pharmacol 57 2001 419 425
3. D.B. Hogan, C.J. Maxwell, T.S. Fung, E.M. Ebly Canadian Study of Health and Aging Prevalence and potential consequences of benzodiazepine use in senior citizens: results from the Canadian Study of Health and Aging Can J Clin Pharmacol 10 2003 72 77
4. P. Carrasco-Garrido, R. Jimenez-Garcia, P. Astasio-Arbiza, P. Ortega-Molina, and A.G. de Miguel Psychotropics use in the Spanish elderly: Predictors and evolution between years 1993 and 2003 Pharmacoepidemiol Drug Saf 16 2007 449 457
5. A. Windle, E. Elliot, K. Duszynski, and V. Moore Benzodiazepine prescribing in elderly Australian general practice patients Aust N Z J Public Health 31 2007 379 381
6. European Medicines Agency. Summary of product characteristics for benzodiazepines as anxiolytics or hypnotics. Available from: www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/09/WC500003774.pdf 1994 [cited 2012].
7. E. Gorevski, B. Bian, C.M. Kelton, J.E. Martin Boone, and J.J. Guo Utilization, spending, and price trends for benzodiazepines in the US Medicaid program: 1991-2009 Ann Pharmacother 46 2012 503 512
8. M. Li, A. Szabo, and H.C. Rosenberg Down-regulation of benzodiazepine binding to alpha 5 subunit-containing gamma-aminobutyric acid(A) receptors in tolerant rat brain indicates particular involvement of the hippocampal CA1 region J Pharmacol Exp Ther 295 2000 689 696
9. A.J. Greenshaw Neurotransmitter interactions in psychotropic drug action: Beyond dopamine and serotonin J Psychiatry Neurosci 28 2003 247 250
10. C.S. Wu, S.C. Wang, I.S. Chang, and K.M. Lin The association between dementia and long-term use of benzodiazepine in the elderly: Nested case-control study using claims data Am J Geriatr Psychiatry 17 2009 614 620
11. C.S. Wu, T.T. Ting, S.C. Wang, I.S. Chang, and K.M. Lin Effect of benzodiazepine discontinuation on dementia risk Am J Geriatr Psychiatry 19 2011 151 159
12. J. Gallacher, P. Elwood, J. Pickering, A. Bayer, M. Fish, and Y. Ben-Shlomo Benzodiazepine use and risk of dementia: Evidence from the Caerphilly Prospective Study (CaPS) J Epidemiol Community Health 66 2012 869 873
13. S. Billioti de Gage, B. Begaud, F. Bazin, H. Verdoux, J.F. Dartigues, K. Peres, and et al. Benzodiazepine use and risk of dementia: Prospective population based study BMJ 345 2012 e6231
14. J. Fastbom, Y. Forsell, and B. Winblad Benzodiazepines may have protective effects against Alzheimer disease Alzheimer Dis Assoc Disord 12 1998 14 17
15. R. Lagnaoui, M. Tournier, Y. Moride, C. Wolfson, T. Ducruet, B. Begaud, and et al. The risk of cognitive impairment in older community-dwelling women after benzodiazepine use Age Ageing 38 2009 226 228
16. R. Lagnaoui, B. Begaud, N. Moore, A. Chaslerie, A. Fourrier, L. Letenneur, and et al. Benzodiazepine use and risk of dementia: A nested case-control study J Clin Epidemiol 55 2002 314 318
17. S. Billioti de Gage, Y. Moride, T. Ducruet, T. Kurth, H. Verdoux, M. Tournier, and et al. Benzodiazepine use and risk of Alzheimer's disease: Case-control study BMJ 349 2014 g5205
18. A. Alperovitch Vascular factors and risk of dementia: Design of the three-city study and baseline characteristics of the study population Neuroepidemiology 22 2003 316 325
19. N. Lechevallier-Michel, M. Gautier-Bertrand, A. Alperovitch, C. Berr, J. Belmin, S. Legrain, and et al. Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: Results from the 3C study Eur J Clin Pharmacol 60 2005 813 819
20. A. Alperovitch, M. Blachier, A. Soumare, K. Ritchie, J.F. Dartigues, S. Richard-Harston, and et al. Blood pressure variability and risk of dementia in an elderly cohort, the Three-City Study Alzheimers Dement 10 2014 S330 S337
21. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
22. B. Isaacs, and A.T. Kennie The Set test as an aid to the detection of dementia in old people Br J Psychiatry 123 1973 467 470
23. Association AP Diagnostic and statistical manual of mental disorders: DSM-IV 4th ed. 1994 American Psychiatric Association Washington, DC
24. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease Neurology 34 1984 939 944
25. L. Radloff The CES-D scale: A self-report depression scale for research in the general population Appl Psych Meas 1 1977 385 401
26. R. Fuhrer, F. Rouillon La version Française de l'échelle CES-D (Center for Epidemiologic Studies-Depression Scale) Description et traduction de l'échelle d'auto-évaluation Pyschiatr Psychobiol 4 1989 181 190
27. C. Tannenbaum, A. Paquette, S. Hilmer, J. Holroyd-Leduc, and R. Carnahan A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs Drugs Aging 29 2012 639 658
28. E. Grober, R.B. Lipton, C. Hall, and H. Crystal Memory impairment on free and cued selective reminding predicts dementia Neurology 54 2000 827 832
29. C. Dufouil, P. Ducimetiere, and A. Alperovitch Sex differences in the association between alcohol consumption and cognitive performance. EVA Study Group. Epidemiology of Vascular Aging Am J Epidemiol 146 1997 405 412